Xiamen SpacegenCo., Ltd., integrating R & D, production, sales and advisory services, is dedicated to providing the most innovative products and services for cancer, genetic diseases and other personalized precision medical testing. We provide the products with total solution for early screening, disease diagnosis, personalized drug selection and efficacy monitoring of treatments.
Spacegen covers an area of 3500 ㎡GMP-compliant manufacturing plant,2000㎡R&D/QC lab and is equipped with high-throughput sequencing platforms, real time PCR platforms, digital PCR platforms and nucleic acid mass spectromrtry platform etc ., developing a series of personalized medical products based on the technology platforms mentioned above.
Spacegen has received EN ISO 13485 certification for medical device quality management. Eleven products have been achieved CE certification. CE certifications for more products are been applied now.
Core technology patent RingCap® has been authorized by the State Intellectual Property Office, and the other 19 domestic invention patents and 1 international invention PCT patent have been submitted.